TABLE OF CONTENTS
|  |  |  | Volume 22, Issue 10 (October 2015) |  | In this issue Original Articles Short Commumication
Also new    AOP | |  |  |  | Advertisement |  | | Original Articles | Top |  | Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironmentM Zhang, L Yan and J A Kim Cancer Gene Ther 2015 22: 463-474; advance online publication, September 25, 2015; 10.1038/cgt.2015.42 Abstract | Full Text |  |  |  | Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinomaX Zhang, Y Zhang, J Yang, S Li and J Chen Cancer Gene Ther 2015 22: 475-480; advance online publication, September 18, 2015; 10.1038/cgt.2015.44 Abstract | Full Text |  |  |  | Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinomaH Pandit, W Zhang, Y Li, S Agle, X Li, S P Li, G Cui, Y Li and R C G Martin Cancer Gene Ther 2015 22: 481-486; advance online publication, September 18, 2015; 10.1038/cgt.2015.46 Abstract | Full Text |  |  |  | Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapsesS Kuramitsu, M Ohno, F Ohka, S Shiina, A Yamamichi, A Kato, K Tanahashi, K Motomura, G Kondo, M Kurimoto, T Senga, T Wakabayashi and A Natsume Cancer Gene Ther 2015 22: 487-495; advance online publication, October 9, 2015; 10.1038/cgt.2015.47 Abstract | Full Text |  |  |  | Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoidsY R Somnay, B Z Dull, J Eide, R Jaskula-Sztul and H Chen Cancer Gene Ther 2015 22: 496-505; advance online publication, September 25, 2015; 10.1038/cgt.2015.49 Abstract | Full Text |  | Short Commumication | Top |  | HSV-1 as a novel therapy for breast cancer meningeal metastasesD Kuruppu and K K Tanabe Cancer Gene Ther 2015 22: 506-508; advance online publication, September 18, 2015; 10.1038/cgt.2015.43 Abstract | Full Text |  |  |  |  | Advertisement |  | Introducing HGV Database
The HGV Database is a fully searchable online database of genome variations published in peer-reviewed Data Reports in Human Genome Variation
Search and filter by specific disease, gene, region, population. Try it now | | |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment